How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA?
{{output}}
Since the introduction of biologic therapies that target tumor necrosis factor (TNF), short-term and long-term outlooks for many patients with rheumatoid arthritis have greatly improved. Not all patients, however, respond to therapy with these agents. Furtherm... ...
